ARNHEM, Netherlands, March 11, 2024 /PRNewswire/ -- PulseCath B.V., a leader in the expanding field of percutaneous ventricular assist devices for high-risk PCI, proudly announces the successful ...
Pulsecath BV secured a CE mark under the Medical Device Regulation (MDR) for its Ivac 2L system, a percutaneous mechanical circulatory support device, four years after it began the process. “It took ...
Partnership accelerates the development of the iVAC 2L mechanical circulatory device in Greater China. Expands Huadong Medicine's medical portfolio for cases of high-risk PCI with innovative ...
ARNHEM, Netherlands, March 11, 2024 /PRNewswire/ -- PulseCath B.V., a leader in the expanding field of percutaneous ventricular assist devices for high-risk PCI, proudly announces the successful ...